<p>Quantification of EAAT1, EAAT2, GFAP and MAP2 immunofluorescence per unit area of slices exposed to 7 days RA, SH or IH in presence (+ve) or in absence (-ve) of 100 µM ceftriaxone. Data are presented as mean immunofluorescence <u>+</u> SD. n = 4-13 for RA<sup>+</sup>, IH<sup>+</sup>, SH<sup>+</sup>; n = 5–11 for RA<sup>-</sup>, IH<sup>-</sup>, SH *: IH<sup>-</sup> or SH<sup>-</sup> - (p≤0.01). <sup>+</sup>: IH<sup>+</sup> < SH<sup>+</sup> (p≤0.01).</p
<p>Changes in % area of expression of CYP1A1 protein in SH-SY5Y cells (<b>A</b>) and U373-MG cells (...
<p>Schematic illustration of relevant reactions from the TCA cycle and glutaminolysis. Absolute intr...
<p>Changes in % area of expression of CYP2B6 protein in SH-SY5Y cells (<b>A</b>) and U373-MG (<b>B</...
<p>Propidium iodide staining quantification of ceftriaxone (+) treated slices exposed to RA, SH and ...
<p>EAAT1, EAAT2, GFAP and MAP2 immunoreactivity in slices exposed to 7 days RA, SH or IH. EAAT1 and ...
<p>Propidium iodide staining (A) and quantification of PI positive cells presented as mean <u>+</u> ...
<p>(A) Immunofluorescence staining of GFAP (green) and nuclear staining (blue) in C8-D1A cells, scal...
<p><b>A</b>–<b>C</b>: Representative examples of immunoreactivity associated with synapsin (<b>A</b>...
<p>a glutamate groups (GLUs): PC12 cells received 5 mM glutamate and then maintained for 24 h.</p><p...
<p><b>A.</b> Representative immuno-blot demonstrating the presence of truncated forms of GAD65 and G...
<p>In this example, the group I selective mGluR agonist, DHPG, was applied to NM on one side of the ...
<p>RT-PCR results for GFAP and NF200 mRNA in C6 (b) and IMR-32 (f) cells, respectively and their rel...
<p>A: Immunofluorescence staining for GFAP and CCL20 in astrocytes with different treatments (Bar = ...
<p>Western blots illustrate Nrf2 protein concentration in whole cell lysate and nuclear fraction usi...
<p>Cell viability and toxicity of various concentrations of glutamate was assayed by MTT and LDH ass...
<p>Changes in % area of expression of CYP1A1 protein in SH-SY5Y cells (<b>A</b>) and U373-MG cells (...
<p>Schematic illustration of relevant reactions from the TCA cycle and glutaminolysis. Absolute intr...
<p>Changes in % area of expression of CYP2B6 protein in SH-SY5Y cells (<b>A</b>) and U373-MG (<b>B</...
<p>Propidium iodide staining quantification of ceftriaxone (+) treated slices exposed to RA, SH and ...
<p>EAAT1, EAAT2, GFAP and MAP2 immunoreactivity in slices exposed to 7 days RA, SH or IH. EAAT1 and ...
<p>Propidium iodide staining (A) and quantification of PI positive cells presented as mean <u>+</u> ...
<p>(A) Immunofluorescence staining of GFAP (green) and nuclear staining (blue) in C8-D1A cells, scal...
<p><b>A</b>–<b>C</b>: Representative examples of immunoreactivity associated with synapsin (<b>A</b>...
<p>a glutamate groups (GLUs): PC12 cells received 5 mM glutamate and then maintained for 24 h.</p><p...
<p><b>A.</b> Representative immuno-blot demonstrating the presence of truncated forms of GAD65 and G...
<p>In this example, the group I selective mGluR agonist, DHPG, was applied to NM on one side of the ...
<p>RT-PCR results for GFAP and NF200 mRNA in C6 (b) and IMR-32 (f) cells, respectively and their rel...
<p>A: Immunofluorescence staining for GFAP and CCL20 in astrocytes with different treatments (Bar = ...
<p>Western blots illustrate Nrf2 protein concentration in whole cell lysate and nuclear fraction usi...
<p>Cell viability and toxicity of various concentrations of glutamate was assayed by MTT and LDH ass...
<p>Changes in % area of expression of CYP1A1 protein in SH-SY5Y cells (<b>A</b>) and U373-MG cells (...
<p>Schematic illustration of relevant reactions from the TCA cycle and glutaminolysis. Absolute intr...
<p>Changes in % area of expression of CYP2B6 protein in SH-SY5Y cells (<b>A</b>) and U373-MG (<b>B</...